This review summarises important pharmacological and clinical characteristics of paliperidone palmitate 3-monthly formulation which is a long-acting intramuscular injection for the maintenance treatment of schizophrenia.
Independent expert commentary provided by Professor Nagesh Pai, who is the Foundation Professor
of Psychiatry at the Graduate School of Medicine, Faculty of Science, Health & Medicine, and University of Wollongong, Australia.
Please login below to download this issue (PDF)